Stony Brook, NEW%20YORK2 Active Studies

Ankylosing Spondylitis Clinical Trials in Stony Brook, NEW%20YORK

Find 2 actively recruiting ankylosing spondylitis clinical trials in Stony Brook, NEW%20YORK. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
301
Enrolling

Recruiting Ankylosing Spondylitis Studies in Stony Brook

About Ankylosing Spondylitis Clinical Trials in Stony Brook

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Stony Brook, NEW%20YORK. These studies are seeking a combined 301 participants. Research is being sponsored by Stony Brook University, West-Ward Pharmaceutical. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Stony Brook — FAQ

Are there ankylosing spondylitis clinical trials in Stony Brook?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Stony Brook, NEW%20YORK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stony Brook?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stony Brook research site will contact you about next steps.

Are clinical trials in Stony Brook free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stony Brook studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Stony Brook are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov